Health Care Slips As Investors Hedge On Vaccine Profit Prospects - Health Care Roundup

Health-care companies fell as investors hedged their bets on the financial implications of rising global demand for Covid 19 vaccines.

U.S. health regulators have for the first time cleared a Covid-19 vaccine's use in children, paving the way for many to be immunized before summer camps and the start of the next school year.

AstraZeneca fell as shareholders opposed its executive pay policy at the U.K. drug giant's annual meeting.

Caris Life Sciences received an $830 million infusion from a group led by Sixth Street Partners, the companies said, the latest sign of private equity's enthusiasm for investing at the intersection of healthcare and technology.

Write to Rob Curran at [e-mail]

(END) Dow Jones Newswires

05-11-21 1620ET